Maggie Throup
Conservative - Former Member for Erewash
First elected: 7th May 2015
Left House: 30th May 2024 (Dissolution)
4 APPG memberships (as of 30 May 2024)
Antimicrobial Resistance, Diagnostics, Furniture Industry, Vaccinations for All23 Former APPG memberships
Antibiotics, Arts, Health and Wellbeing, Blood Cancer, Community Transport, East Midlands, East-West Rail, Fairtrade, Freight, Freight Transport, Haemophilia and Contaminated Blood, Health, Heart Disease, HIV and AIDS, Human Trafficking and Modern Slavery, Life Sciences, Nutrition for Development, Obesity, Retail Crime, Smoking and Health, Stem Cell Transplantation, Vascular and Venous Disease, Waterways, WhistleblowingDivision Voting information
Maggie Throup voted No - against a party majority and in line with the House
One of 122 Conservative No votes vs 126 Conservative Aye votes
Tally: Ayes - 139 Noes - 422
All Debates
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
Sparring Partners
(58 debate interactions)
(34 debate interactions)
(22 debate interactions)
Department Debates
(460 debate contributions)
(69 debate contributions)
(40 debate contributions)
(38 debate contributions)
Legislation Debates
(5,440 words contributed)
(5,440 words contributed)
(2,637 words contributed)
(2,504 words contributed)
Latest EDMs signed by Maggie Throup
Commons initiatives
These initiatives were driven by Maggie Throup, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Maggie Throup has not been granted any Urgent Questions
1 Adjournment Debate led by Maggie Throup
1 Bill introduced by Maggie Throup
A Bill to require commercial organisations and public bodies to include a statement on slavery and human trafficking in their annual report and accounts; and to require contracting authorities to exclude from procurement procedures economic operators who have not provided such a statement; and for connected purposes.
Wednesday 30th November 2016
6 Bills co-sponsored by Maggie Throup
Sun Protection Products (Value Added Tax) Bill 2022-23
Sponsor - Amy Callaghan (SNP)
Sale of Tobacco (Licensing) Bill 2022-23
Sponsor - Bob Blackman (Con)
Forensic Science Regulator Bill 2017-19
Sponsor - Chris Green (Con)
Electric Vehicles (Standardised Recharging) Bill 2017-19
Sponsor - Bill Wiggin (Con)
Registration of Marriage (No. 2) Bill 2017-19
Sponsor - Caroline Spelman (Con)
Service Animals (Offences) Bill 2017-19
Sponsor - Oliver Heald (Con)
Latest 50 Written Questions
(View all written questions)1 Other Department Questions
We are grateful to the DCMS Committee for its wide-ranging report on the future of the National Lottery and the lotteries sector. The Department and the Gambling Commission have now submitted responses to the Committee’s recommendations.
Opposition Chief Whip (Commons)
It is essential we put a stop to the immoral behaviour we have seen from some charities over the summer and rebuild people’s faith in giving to charity.
There will be a new, tougher fundraising regulator which will own and develop the fundraising code of conduct, have the power to stop fundraising campaigns if they are in breach of the rules, name and shame those who do not comply and refer cases to the Charity Commission. It will also establish a Fundraising Preference Service to enable people to reset their consent to receive charity fundraising requests.
We are also seeking reserve powers to mandate charities to register with the new fundraising regulator should this prove necessary.
3 Department for Science, Innovation & Technology Questions
(View all Maggie Throup's DSIT questions)As set out in ARIA’s Framework Agreement, ARIA will have maximum autonomy over its research and project choice; its procedures; and its institutional culture. Decisions on the programme portfolio will be set by ARIA, not ministers, and allocation of funding to research projects will be decided by those with relevant technical expertise.
Over the coming months, ARIA is recruiting its first cohort of Programme Directors, who will help to shape and inform the Agency’s first set of research programmes.
The £1.6bn returned to HM Treasury, was part of funding put aside in the Spending Review for association to Horizon Europe. As we have been unable to associate in the financial year 2022/23, the departmental underspend was returned to the Exchequer. Any funding required for association in future years will be made available once there is clarity on UK association to EU programmes.
Regardless of whether we reach an agreement with the EU on association, or launch our proposed alternative, the Government will ensure that UK researchers and businesses continue to benefit from world-leading collaboration opportunities in Europe and beyond.
The Government has committed £1.5bn in additional resources to support people fleeing oppression in Ukraine and Afghanistan. Recognising these significant and unanticipated costs, the UK remains committed to the use of ODA to fund research that can provide new solutions to critical challenges in development, and. We have robust mechanisms in place to assess the impact and value-for-money of our ODA-funded research programmes, which along with the priorities established by UK International Development Strategy, such as global health, are used to inform spending decisions on projects such as those linked to Antimicrobial Resistance.
1 Department for Business, Energy and Industrial Strategy Questions
(View all Maggie Throup's BEIS questions)There is no single data repository for historical information on cross-government investment into energy research, development and demonstration (RD&D). The best available record of government investment in renewable energy technologies is the International Energy Agency’s (IEA) Energy Technology RD&D Budget Database, which this Department and its predecessor (Department of Energy and Climate Change) contribute to. The IEA’s database allows users to track trends in spending by energy technology in IEA countries back to 1974 and can be found at: http://www.iea.org/statistics/rdd/.
However, including other spending beyond that included in the IEA statistics, since 2008, the Government has invested over £60m in marine energy research, development, demonstration and deployment contributing towards both wave and tidal stream energy.
1 Department for Digital, Culture, Media & Sport Questions
(View all Maggie Throup's DCMS questions)
There is a significant body of evidence that demonstrates that systematic phonics is a highly effective method for teaching early reading. According to the Education Endowment Foundation (EEF), phonics approaches have been consistently found to be effective in supporting younger readers to master the basics of reading, with an average impact of an additional four months’ progress. Research suggests that phonics is particularly beneficial for younger pupils (four to seven year olds) as they begin to read. Teaching phonics is more effective on average than other approaches to early reading (such as whole language or alphabetic approaches), though it should be emphasised that effective phonics techniques are usually embedded in a rich literacy environment for early readers and are only one part of a successful literacy strategy[1].
In 2018 there were 163,000 more six year olds in England on track to become fluent readers compared to 2012. This represented 82% of pupils meeting the expected standard in the phonics screening check, compared to just 58% when the check was introduced in 2012.
The Department is investing £26 million in a national network of English hubs to support local schools in developing their teaching practice, with a focus on systematic phonics, early language development and reading for pleasure. There are now 34 such hubs, based in primary schools across England.
[1] EEF Phonics Teaching and Learning Toolkit, updated August 2018 (available at: https://educationendowmentfoundation.org.uk/evidence-summaries/teaching-learning-toolkit/phonics/).
At Key Stage 4, all pupils in maintained schools have an entitlement to study an arts subject and a design and technology subject.
In addition to the revised curriculum introduced into schools in 2014, new GCSEs in a number of creative, artistic, and technical subjects including music, art and design, dance, drama, design and technology, food preparation and nutrition, electronics and engineering have been developed to be more rigorous.
These GCSEs or any other GCSEs and technical awards from the Department approved list can count towards the open element of Progress and Attainment 8. These measures are designed to encourage schools to offer a broad and balanced curriculum.
We want all pupils to be healthy and active. Since 2013, we have invested over £600 million of ring-fenced funding to improve PE and sport in primary schools through the Primary PE and Sport premium. Evidence indicates that the funding is having a major impact, with 84% of schools reporting an increase in pupil engagement in PE during curricular time and in the levels of participation in extra-curricular activities.
Schools have the freedom to decide how best to use the funding based on the needs of their pupils, and the evidence indicates that the majority of schools are already targeting some of their funding at the least active pupils within their schools.
But we know that there is more to do, which is we have committed to using revenue from the soft drinks industry levy to double the primary PE and sport premium to £320 million a year from September 2017. This will enable schools to make further improvements to the quality and breadth of their PE and sport provision.
The commitments agreed at the London Summit could potentially achieve major benefits for developing countries including preventing their resources from being stolen and hidden abroad; ensuring international systems recover these funds whilst punishing perpetrators; and helping citizens have greater opportunities to seek justice against corruption.
The UK Government is committed to ensuring developing countries can reduce poverty through trading opportunities and that such impacts are taken into account in our trade policy. Trade was a key component of the G7 summit this year with commitments on Aid for Trade that will help African countries to negotiate and implement trade agreements. The G20 also expressed support at the recent summit for low-income countries to participate in Global Value Chains.
Ministers regularly discuss a range of issues with their counterparts in other Government departments. Utility companies have a right of access to the highway to install and repair the apparatus on which we all rely. Highway authorities have duties to coordinate works on their networks and to secure the expeditious movement of traffic. The Government has introduced a number of initiatives, such as the development of Street Manager, and regulatory changes all designed to improve the efficiency of how works are carried out.
The Police have a range of options when enforcing against road traffic offenders. If a driver is pulled over at the road side, a Fixed Penalty Notice can be issued on-the-spot for a range of offences as an alternative to prosecution.
In 2018, the Government began engaging on the design of HS2 Phase 2b with local communities along the route, via the publication of the Working Draft Environmental Statement.
In June 2019, we published a Design Refinement Consultation which announced eleven possible changes to the Phase 2b route. These consultations represent significant milestones in preparing the HS2 Phase 2b hybrid Bill.
The Bus Services Act 2017 includes powers for the Secretary of State to make Regulations requiring bus operators to provide audible and visible information on local bus services in Great Britain.
The Government understands the importance of accessible on-board information in helping bus passengers to travel with confidence, and in Summer 2018 published a public consultation on proposals to require its provision on local bus services throughout Great Britain. This follows the Government’s commitment, set out in the Inclusive Transport Strategy, to invest £2 million towards ensuring that audio visual equipment is installed on buses.
We continue to analyse responses to the consultation and expect to announce our next steps regarding the making of Regulations and publication of guidance later in the year.
Highways England are converting the existing M1 between Junctions 23a and 25 into a smart motorway to increase capacity and improve journeys. There are no plans to make provision for any future restoration of the Derby and Sandiacre canal by building a tunnel under the M1 as part of this scheme.
Highways England is aiming to commence construction of the M1 J24 to J25 smart motorway scheme in 2016/17 with completion in 2017/18. M1 J23a to J24 is being developed and Highways England is currently committed to commencing construction on this section in 2019/20. Highways England is currently considering combining these works to ensure the most efficient and effective delivery and minimise disruption to the travelling public. Work continues on developing these proposals and in due course Highways England will be able to confirm the final programme for delivery of M1 J23a to J25.
In line with the recommendations of the Richards’ Review (2021), community diagnostic centres (CDCs) must offer a minimum set of diagnostic services across the following core modalities:
- imaging, for example, computerised tomography, magnetic resonance imaging;
- physiological measurement, for example, echocardiography, spirometry; and
- pathology, for example, phlebotomy, urine testing.
Large CDCs must also offer endoscopy services, for example, gastroscopy and colonoscopy, as part of their core offer.
There are no current plans to expand the core list of services required by CDCs. CDCs are however encouraged to offer other tests beyond the minimum requirement where this may be appropriate and deemed to be a priority locally. NHS England does not currently publish a breakdown of all CDC activity.
There are 135 CDCs currently operational, and the CDC programme has delivered over five million tests since reporting in July 2021, which is currently ahead of planned programme activity. The Government has also confirmed it is now on track to meet its target to open up to 160 CDCs by March 2025, and expects to achieve this a year early in March 2024.
NHS England is working on a plan to ensure sufficient workforce capacity, including for community diagnostic centres, to enable workforce expansion with the right skills and roles, in the right locations and at the right time. In 2022/23, this resulted in over 4,300 new starters across the training pipeline for diagnostics and cancer.
In line with the recommendations of the Richards’ Review (2021), community diagnostic centres (CDCs) must offer a minimum set of diagnostic services across the following core modalities:
- imaging, for example, computerised tomography, magnetic resonance imaging;
- physiological measurement, for example, echocardiography, spirometry; and
- pathology, for example, phlebotomy, urine testing.
Large CDCs must also offer endoscopy services, for example, gastroscopy and colonoscopy, as part of their core offer.
There are no current plans to expand the core list of services required by CDCs. CDCs are however encouraged to offer other tests beyond the minimum requirement where this may be appropriate and deemed to be a priority locally. NHS England does not currently publish a breakdown of all CDC activity.
There are 135 CDCs currently operational, and the CDC programme has delivered over five million tests since reporting in July 2021, which is currently ahead of planned programme activity. The Government has also confirmed it is now on track to meet its target to open up to 160 CDCs by March 2025, and expects to achieve this a year early in March 2024.
The Department has no current plans to provide healthcare providers with training in gender-sensitive and culturally competent care for women seeking HIV services. Individual employers providing HIV care are responsible for ensuring their staff are trained and competent to carry out their role.
The standard of training for health care professionals is the responsibility of respective independent statutory regulatory bodies who set the outcome standards expected at undergraduate level and approve courses. It is the responsibility of higher education institutions to write and teach the curricula content that enables their students to meet the regulators’ outcome standards.
HIV Prevention England (HPE) is the national HIV prevention programme for England and is funded at £3.5 million by the Department. The programme aims to support communities who are disproportionately affected by HIV, including gay, bisexual and men who have sex with men and Black African heterosexual men and women.
The Department has appointed Terrence Higgins Trust, a national charity who provide services related to sexual heath and HIV, to deliver the programme from 2021-2024. HPE delivers a nationally co-ordinated programme of HIV prevention work that is designed to complement locally commissioned prevention activities in areas with high HIV prevalence and for communities at risk of HIV transmission, with a particular focus on women. HPE also aims to improve knowledge and understanding of HIV transmission and reduce stigma within affected communities through the delivery of public campaigns such as National HIV Testing Week, and evidence-based HIV prevention interventions in partnership with local organisations and charities, including women-led organisations.
HPE work with a wide range of models and their network of influencers. As part of HPE campaigns, a range of people share their stories and experiences on HIV, STIs and sexual health this includes women and other people who are likely to be recognisable to specific demographics.
The HIV Action Plan is the cornerstone of our approach in England to drive forward progress and achieve our goal to end new HIV transmissions, AIDS and HIV-related deaths within England by 2030. A key principle of our approach is to ensure that all populations benefit equally from improvements made in HIV outcomes, including women.
The UK Health Security Agency (UKHSA) publish a yearly monitoring and evaluation report, which sets out key indicators to track progress towards our ambitions in the HIV Action Plan, including by gender, and this data helps system partners to understand where services can be improved and made more accessible to key populations. The next report will be published on 1 December 2023.
The Department commissions research through the National Institute for Health and Care Research (NIHR), which also funds Health Protection Research Units (HPRUs) to help build an evidence base for public health policy and practice in partnership with UKHSA. The NIHR HPRU in bloodborne and sexually transmitted infections at University College London has ongoing research to determine the levels of awareness of and interest in HIV pre-exposure prophylaxis (PrEP) among women and how this relates to equity factors and HIV risk.
Policy options based on the Joint Committee on Vaccination and Immunisation’s advice on a potentially expanded vaccination programme for respiratory syncytial virus are currently being developed by the Department, working with the UK Health Security Agency and NHS England. The Government will then announce its plans once complete.
The Department is guided by the independent Joint Committee on Vaccination and Immunisation (JCVI) on the approach to the immunisation programmes in England. Their decision is informed by the cost effectiveness of different vaccines and different vaccine policies, which evaluate the health impacts of vaccines versus the costs. However, they do not consider the impact on the economy. The Department will continue to be guided by JCVI advice, which is based on a cost-effectiveness approach to appraising vaccines.
The Department’s objective is to improve the health of the population. Influenza has a significant impact in terms of morbidity and mortality. It will also have an economic impact, as do most other health conditions. Vaccines are the best defence we have against respiratory infections such as flu. They provide good protection against hospitalisation and death. They also reduce the risk of long-term symptoms.
Vaccine uptake rates are considered in the planning for future vaccination programmes. However, no assessment has been made of the potential impacts of changes to the eligibility criteria for flu and COVID-19 vaccines on vaccine uptake rates. This is because the primary aim of the COVID-19 and flu vaccination programme continues to be the prevention of severe disease (hospitalisation and mortality) and vaccination is therefore offered to those at greatest risk of serious disease.
It is vitally important that everyone takes up the vaccinations to which they are entitled; for themselves, their families and wider society. The Department continues to use the best available evidence to demonstrate the health benefits of vaccinations at both a personal and population level, and highlights these messages through regular media, stakeholder and social media engagement. The Department also works closely with both NHS England and the UK Health Security Agency to develop vaccination guides and patient facing consent resources to demonstrate the benefits of vaccinations for all, as well as ensuring that reputable sources such as NHS.UK or GOV.UK are prominent and readily signposted.
A paid for campaign to promote uptake of seasonal flu and COVID-19 booster vaccinations for this season is in development, due to launch in early November 2023.
The UK Health Security Agency collects data on shingles vaccine uptake including immunocompromised individuals. This data collection has been in place since the start of the programme in September 2021. Data will be published subject to quality validation processes.
A plan is in place to collect data to monitor the uptake in new cohorts who will be eligible for Shingrix from 1 September 2023, with the intention to publish this data in February 2024.
There is currently an existing, targeted immunisation programme in place to protect infants at high risk of complications if infected by respiratory syncytial virus (RSV).
To support the effective management of infection levels, the UK Health Security Agency (UKHSA) will monitor weekly levels of RSV and bronchiolitis, a condition associated with RSV in young children. UKHSA also leads public health messaging on social, national, and regional media, highlighting the signs and symptoms of RSV and the steps which can be taken to reduce infections, including reducing risks to babies.
Policy options based on the Joint Committee on Vaccination and Immunisation’s advice on a potentially expanded vaccination programme for respiratory syncytial virus are currently being developed by the Department, working with the UK Health Security Agency and NHS England.
The Department is guided by the independent Joint Committee on Vaccination and Immunisation (JCVI) on the approach to the immunisation programmes in England. Details about the flu vaccination programme for 2023/24, including which groups will be eligible for a free vaccine and the vaccines that will be reimbursable to National Health Service providers, were published on 25 May 2023. The groups eligible for a free flu vaccine for the 2023 to 2024 season include those aged 65 years and over and those aged six months to under 65 years in clinical risk groups.
During the COVID-19 pandemic, eligibility for the influenza programme was temporarily extended to include all adults aged between 50 and 64 years of age to protect the population from the potential threat of cocirculation of COVID-19 and influenza and alleviate pressure on the NHS. In the JCVI’s advice for the 2023/24 programme published in November 2022, it stated that whilst there would be a health benefit in vaccinating low risk 50–64-year-olds, it is uncertain whether this would be cost effective and that the overall priority should be to extend the childhood programme in secondary schools as this would be more cost effective and likely to have a greater impact on morbidity and mortality compared with vaccinating 50-64 year olds. An expansion of the flu programme to include secondary school-aged children was announced on 4 July 2023.
We do not have all the information in the format requested.
Please see the attachment for the information provided.
Flu vaccine uptake is published at the following links:
We do not have all the information in the format requested.
Please see the attachment for the information provided.
This information is published at the following links:
The Department together with the National Health Service and UK Health Security Agency are providing advice and information to support those getting the COVID-19 and flu vaccines and to anyone who might have questions about the vaccination process.
Our communications include information and advice shared via television, radio and social media. This has been translated into 28 languages including Albanian, Arabic, Brazilian, Chinese, Hindi, Polish, Tagalog and Urdu. A new country-wide marketing campaign urging millions of eligible people to get their flu and COVID-19 booster vaccines to top up their immunity was launched on 24 October 2022. This includes targeted communications for ethnic minority communities, with a particular focus on those with low vaccine confidence.
Multicultural community activity is seeing teams of campaign ambassadors engage with a range of different ethnic groups who tend to be more vaccine hesitant. This is taking place across the country in high footfall places of worship and nearby community settings.
The information requested is not held centrally. However, the United Kingdom Health Security Agency (UKHSA) publish seasonal influenza vaccine uptake in general practitioner patients. The following table shows the provisional monthly data for 1 September 2022 to 30 November 2022 for various cohorts and seasonal influenza vaccine uptake provisional data for all school aged primary school children in England given from the 1 September 2022 to the 30 November 2022.
Cohort | Uptake 30 November 2022 (%) |
65 years old and over | 76.2 |
6 months old to under 65 years old at-risk | 42.7 |
Pregnant women | 30.0 |
50 years old to under 65 years old and not in a clinical risk group | 35.6 |
50 years old to 65 years old and in a clinical risk group | 56.7 |
All 2 year olds (combined) | 34.5 |
All 3 year olds (combined) | 36.7 |
Reception (age 4 years old to 5 years old) | 47.8 |
Year 1 (age 5 years old to 6 years old) | 48.3 |
Year 2 (age 6 years old to 7 years old) | 49.3 |
Year 3 (age 7 years old to 8 years old) | 48.9 |
Year 4 (age 8-9 years old) | 48.2 |
Year 5 (age 9-10 years old) | 47.5 |
Year 6 (age 10-11 years old) | 46.0 |
All primary school age (age 4 years old to 11 years old) | 48.0 |
Source: Seasonal influenza vaccine uptake in GP patients: monthly data, 2022 to 2023 and Seasonal influenza vaccine uptake in children of school age: monthly data, 2022 to 2023, UKHSA
Data for December 2022 will be published at the end of January 2023 and data for secondary school aged children will be published on 26 January 2023.
UKHSA has published provisional data for Seasonal influenza uptake amongst frontline healthcare workers (HCWs) in England 2022 to 2023 for the period 1 September 2022 to 30 November 2022, it is 41.8%. The data for December 2022 will be published at the end of January 2023.
As of the week, ending 18 December 2022, the proportions who had received their flu vaccination for the 2022 to 2023 season were, 70.1% of total residents and 13.8% of total staff of older adult care homes:
Vaccine uptake for carers will be published in the 2022 to 2023 annual report
The 2022/23 campaign to promote uptake of seasonal flu and COVID-19 booster vaccinations had a media spend of £3.02 million. This was an integrated winter vaccinations campaign therefore it is not possible to split out the spend by vaccine. The 2021/22 campaign to promote uptake of seasonal flu and COVID-19 booster vaccinations had a media spend of £11.5 million. This was also an integrated winter vaccinations campaign and spend cannot be separated out by vaccine.
The information requested is not held. However, the following table shows the booster uptake in age group from 50 years old to 90 years old and over by 30 November 2022 and 31 December 2022.
| Age Group | Booster uptake 30 November 2022 (%) | Booster uptake 31 December 2022 (%) |
50-54 years old | 38.3 | 41.8 |
55-59 years old | 48.5 | 51.5 |
60-64 years old | 58.1 | 60.8 |
65-69 years old | 70.1 | 71.6 |
70-74 years old | 77.5 | 78.7 |
75-79 years old | 80.8 | 82.1 |
80-84 years old | 81.2 | 82.5 |
85-89 years old | 80.7 | 82.2 |
90+ years old | 77.9 | 79.9 |
Source: https://coronavirus.data.gov.uk/details/vaccinations?areaType=nation&areaName=England
Data on vaccine uptake in pregnant women is published by the UK Health Security Agency (UKHSA) in the Vaccine Surveillance Report, data is available up to June 2022. Of women who gave birth in June 2022, 67.3%, 24,933 of 37,037, had received 2 doses of the vaccine before they gave birth.
The National Health Service publishes data on the total number of people who have had an Autumn Booster dose to date, 12 January for Health Care Workers, immunosuppressed and those at risk in the age bracket, of five years old to 49 years old. Individuals identified as carers in their general practitioner record were included in this cohort but from 1 December 2022 carers are no longer included.
UKHSA publish monthly reports on seasonal influenza and COVID-19 vaccine uptake in frontline healthcare workers. Data published to the end of November 2022 showed that in 165 NHS Trusts providing a return, 338,602 frontline healthcare workers had received a COVID vaccine since 1 September 2022, an uptake of 36.3 %.
NHS England has a statutory duty to carry out an annual performance assessment of each clinical commissioning group (CCG) and, in 2016/17, introduced the CCG Improvement and Assessment Framework. This framework is aligned to delivery of the Five Year Forward View and NHS Planning Guidance.
The Framework brings together in one place NHS Constitution and other core performance and finance indicators, outcome goals and transformational challenges. CCGs are also assessed against a range of indicators that consider their delivery of commitments, improved health outcomes for their populations and whether they are well-led organisations. This provides assurance that CCGs are effective commissioning organisations.
Where necessary, NHS England is supported by legislation in exercising formal powers of direction if it is satisfied that a CCG is failing or is at risk of failing to discharge its functions.
It is a matter for CCGs to determine how best to commission services to meet the health needs of their local population, and they should have regard to National Institute for Health and Care Excellence guidance in doing so.
No formal assessment has been made of the potential effect of the expiry of the National Stroke Strategy in 2017 on stroke patient outcomes. However the quality of stroke care is continually monitored by the Sentinel Stroke National Audit Programme.
The National Stroke Strategy remains valid and implementation of it continues. Action is being taken to ensure the progress made on stroke continues. This includes;
- ongoing work in virtually all parts of the country to organise acute stroke care to ensure that all stroke patients, regardless of where they live or what time of the day or week they have their stroke, have access to high quality specialist care;
- publication of the Cardiovascular Disease (CVD) Outcomes Strategy in 2013, which includes many stroke specific strategic ambitions;
- a CVD collaborative group is being established to bring together relevant stakeholders in the field of CVD and provide a forum where relevant work being undertaken in this area and potential new initiatives can be discussed and responsibilities for action determined;
- NHS England’s National Clinical Director for Stroke is working with Clinical Networks, Urgent and Emergency Care Networks, Clinical Commissioning Groups (CCGs) and Sustainability and Transformation Plan footprints on how stroke care is best delivered to local communities;
- services for the management of transient ischaemic attack (TIA) are changing in many areas to meet the new standard that all TIA patients should be seen and assessed within 24 hours, not just high risk patients; and
- CCGs are being encouraged to increase the geographical coverage of early supported discharge services.
Prevention of stroke and CVDs is also a priority for NHS England, particularly attempting to reduce the very high prevalence of CVD in patients with mental health illness.
No formal assessment has been made of the potential effect of the expiry of the National Stroke Strategy in 2017 on stroke patient outcomes. However the quality of stroke care is continually monitored by the Sentinel Stroke National Audit Programme.
The National Stroke Strategy remains valid and implementation of it continues. Action is being taken to ensure the progress made on stroke continues. This includes;
- ongoing work in virtually all parts of the country to organise acute stroke care to ensure that all stroke patients, regardless of where they live or what time of the day or week they have their stroke, have access to high quality specialist care;
- publication of the Cardiovascular Disease (CVD) Outcomes Strategy in 2013, which includes many stroke specific strategic ambitions;
- a CVD collaborative group is being established to bring together relevant stakeholders in the field of CVD and provide a forum where relevant work being undertaken in this area and potential new initiatives can be discussed and responsibilities for action determined;
- NHS England’s National Clinical Director for Stroke is working with Clinical Networks, Urgent and Emergency Care Networks, Clinical Commissioning Groups (CCGs) and Sustainability and Transformation Plan footprints on how stroke care is best delivered to local communities;
- services for the management of transient ischaemic attack (TIA) are changing in many areas to meet the new standard that all TIA patients should be seen and assessed within 24 hours, not just high risk patients; and
- CCGs are being encouraged to increase the geographical coverage of early supported discharge services.
Prevention of stroke and CVDs is also a priority for NHS England, particularly attempting to reduce the very high prevalence of CVD in patients with mental health illness.
The information requested is not available.
The Department’s National Institute for Health Research (NIHR) spent £25.5 million on respiratory disease research in 2014/15 (the latest available figure). Most of this investment (£16.6 million in 2014/15) is in infrastructure for respiratory research where spend on specific topics such as the treatment of idiopathic pulmonary fibrosis cannot be separated from total infrastructure expenditure. This infrastructure includes NIHR biomedical research centres and the NIHR Clinical Research Network.
The NIHR manages the Efficacy and Mechanism Evaluation programme, which is funded by the Medical Research Council and NIHR. The programme is currently funding a £1.4 million efficacy and mechanism evaluation of treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole.
NHS England has placed its position on the commissioning of pre-exposure prophylaxis (PrEP) under review. This review of the commissioning process will be undertaken by the Specialised Services Committee of NHS England in late May 2016. Depending on the outcome of that decision, a further decision taking account of the clinical evidence for PrEP, the evidence and demand for other new treatments not currently commissioned and NHS England's available funding and priorities is currently planned for June 2016.
The planning of the process to select test sites, including timing and criteria for selection, will continue alongside NHS England’s review of its position on the commissioning of pre-exposure prophyaxis (PrEP).
Although the transfer is effective from April 2016, the handover process will be agreed between specialised commissioning and individual clinical commissioning groups (CCGs), in line with their preparedness.
Specialised commissioning teams will continue to provide advice and support CCGs post-handover in line with the CCG’s need. CCGs already have mechanisms in place to monitor provider performance and quality through the existing quality assurance processes.
NHS England is not currently able to provide a figure for individual clinical commissioning groups on 1 April 2016 as the basis for calculating the figures is still being finalised.
NHS England is supporting the transfer of commissioning responsibilities to ensure that clinical commissioning groups are fully prepared to assume the role working through collaborative commissioning forums.
NHS England have provided a commissioning information pack including a stocktake of local services, care pathways, waiting times and a quality overview for each local area. National clinical experts are currently finalising commissioning and clinical guidance on standards for the adult obesity surgery pathway.
The draft service specification reflects best practice and describes the standard providers will need to meet for the surgical service.